Fish oil and drug combo may slow prostate cancer in Low-Risk men
NCT ID NCT01653925
First seen Dec 16, 2025 · Last updated May 21, 2026 · Updated 21 times
Summary
This study looks at whether taking marine omega-3 fatty acids (found in fish oil) and a drug called dutasteride can slow or prevent prostate cancer from getting worse in men with low-risk prostate cancer. The 120 participants are already on active surveillance, meaning they are closely monitored instead of receiving immediate treatment. Researchers will measure changes in fatty acid levels and gene activity in prostate tissue to see if these interventions help keep the cancer from progressing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hotel-Dieu of Quebec
Québec, Quebec, G1R 2J6, Canada
-
Institute of nutraceuticals and functional food of Laval University
Québec, Quebec, G1V 0A6, Canada
Conditions
Explore the condition pages connected to this study.